Smart Nanozymes for Cancer Therapy: The Next Frontier in Oncology
Open Access
- 20 July 2023
- journal article
- review article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (25) , e2300768
Abstract
Nanomaterials that mimic the catalytic activity of natural enzymes in the complex biological environment of the human body are called nanozymes. Recently, nanozyme systems have been reported with diagnostic, imaging, and/or therapeutic capabilities. Smart nanozymes strategically exploit the tumor microenvironment (TME) by the in situ generation of reactive species or by the modulation of the TME itself to result in effective cancer therapy. This topical review focuses on such smart nanozymes for cancer diagnosis, and therapy modalities with enhanced therapeutic effects. The dominant factors that guide the rational design and synthesis of nanozymes for cancer therapy include an understanding of the dynamic TME, structure‐activity relationships, surface chemistry for imparting selectivity, and site‐specific therapy, and stimulus‐responsive modulation of nanozyme activity. This article presents a comprehensive analysis of the subject including the diverse catalytic mechanisms of different types of nanozyme systems, an overview of the TME, cancer diagnosis, and synergistic cancer therapies. The strategic application of nanozymes in cancer treatment can well be a game changer in future oncology. Moreover, recent developments may pave the way for the deployment of nanozyme therapy into other complex healthcare challenges, such as genetic diseases, immune disorders, and ageing.Keywords
This publication has 224 references indexed in Scilit:
- Detection of cancer cells in the cerebrospinal fluid: current methods and future directionsFluids and Barriers of the CNS, 2011
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF NanomedicineClinical Cancer Research, 2010
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Facile Synthesis of Ag Nanocubes of 30 to 70 nm in Edge Length with CF3COOAg as a PrecursorChemistry – A European Journal, 2010
- Role of Oxidative Stress in Stem, Cancer, and Cancer Stem CellsCancers, 2010
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?Journal of Nanoparticle Research, 2010
- Molecular Diagnosis and Therapy of Kidney CancerAnnual Review of Medicine, 2010
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Stromal fibroblasts in cancer initiation and progressionNature, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002